Our previous studies revealed that insulin stimulates the tyrosine phosphorylation of caveolin in 3T3L1 adipocytes. To explore the mechanisms involved in this event, we evaluated the association of the insulin receptor with caveolin. The receptor was detected in a triton-insoluble low-density fraction, co-sedimenting with caveolin and flotillin on sucrose density gradients. We also detected the receptor in caveolin-enriched rosette structures by immunohistochemical analysis of plasma membrane sheets from 3T3L1 adipocytes. Insulin stimulated the phosphorylation of caveolin-1 on tyr 14 . This effect of the hormone was not blocked by overexpression of mutant forms of the Cbl Associated
Summary
Our previous studies revealed that insulin stimulates the tyrosine phosphorylation of caveolin in 3T3L1 adipocytes. To explore the mechanisms involved in this event, we evaluated the association of the insulin receptor with caveolin. The receptor was detected in a triton-insoluble low-density fraction, co-sedimenting with caveolin and flotillin on sucrose density gradients. We also detected the receptor in caveolin-enriched rosette structures by immunohistochemical analysis of plasma membrane sheets from 3T3L1 adipocytes. Insulin stimulated the phosphorylation of caveolin-1 on tyr 14 . This effect of the hormone was not blocked by overexpression of mutant forms of the Cbl Associated
Protein CAP that block the translocation of phospho-Cbl to the caveolin enriched, lipid raft microdomains. Moreover, this phosphorylation event was also unaffected by inhibitors of the MAP kinase and PI 3-kinase pathways. Although previous studies demonstrated that the Src family kinase Fyn was highly enriched in caveolae, an inhibitor of this kinase had no effect on insulin-stimulated caveolin phosphorylation. Interestingly,
Introduction
The insulin receptor is a tyrosine kinase that undergoes ligand-stimulated autophosphorylation and activation of its intrinsic substrate kinase activity (1) . Once activated, the receptor phosphorylates intracellular substrates on tyrosine, including members of the insulin receptor substrate family (IRS1/2/3/4), Shc, SIRP, Gab-1, Cbl and APS (2) (3) (4) . Tyrosine phosphorylation of these proteins creates recognition sites for effector molecules containing Src homology 2 (SH2) and phosphotyrosine binding (PTB)
domains. These include the small adapter proteins Grb2, CrkII and Nck, the SHP2
protein tyrosine phosphatase and the regulatory subunit of the type 1A
phosphatidylinositol (PI) 3-kinase (4) . The insulin receptor-dependent tyrosine phosphorylation of both IRS1 and IRS2 are critical in maintaining proper glucose homeostasis through its interaction with the PI 3-kinase (5) (6) (7) (8) (9) . This interaction appears to serve a dual function by stimulating PI 3-kinase activity and targeting the enzyme to a critical intracellular site (10). Studies using various pharmacological inhibitors, microinjection of blocking antibodies, expression of dominant-interfering and constitutively active mutants have consistently demonstrated a necessary role for PI 3-kinase activity in most of the metabolic effects of insulin (11, 12) . Furthermore, inhibition of PI 3,4,5P 3 formation (a product of PI 3-kinase) by expression of the 3' phosphatase pTEN or the 5' phosphatase SHIP prevents insulin-stimulated glucose uptake and Glut4 translocation (13) (14) .
integrin receptors does not induce Glut4 translocation (15, 16, 19) . Furthermore, two naturally occurring insulin receptor mutations were unable to induce Glut4 translocation and glucose uptake, yet were fully capable of activating PI 3-kinase (20) . Additionally, a cell permeable analog of PI(3,4,5)P 3 had no effect on glucose uptake (17) . These data suggest that although the PI 3-kinase pathway is necessary, there is at least one additional pathway required.
Recent data suggest that the second requisite pathway might involve tyrosine phosphorylation events that are restricted to subdomains of the plasma membrane. The insulin-stimulated tyrosine phosphorylation of Cbl results in its appearance in caveolinenriched, lipid raft subdomains of the plasma membrane in 3T3L1 adipocytes (21) (22) (23) .
Cbl is recruited to the insulin receptor by the adapter protein APS, which is necessary for its insulin-stimulated tyrosine phosphorylation (24) . The Cbl and APS proteins form a trimeric complex with the adapter protein CAP, a member of the SoHo family of proteins that contains a flotillin-binding SoHo domain in it amino terminus, and three adjacent SH3 domains in its carboxyl-terminus (22, 23, 25) . Once phosphorylated, the Cbl/CAP complex is recruited to lipid rafts through the interaction of CAP with flotillin.
Expression of dominant-interfering CAP mutants that lack either the SH3 or SoHo domains prevented the localization of this complex to plasma membrane microdomains and inhibit the stimulation of glucose uptake and GLUT4 translocation by insulin (25) .
Following insulin-stimulated tyrosine phosphorylation, Cbl recruits the SH2-containing adapter protein CrkII to lipid rafts; along with the guanine nucleotide exchange factor C3G (21, 23, 26) . Upon its translocation, C3G activates TC10, a member of the Rho family protein of small GTP binding proteins expressed in muscle and adipose tissue (27) . TC10 is specifically activated by insulin in 3T3L1 adipocytes in a CAP-dependent but PI 3-kinase-independent manner (26) . Although the physiologically relevant effectors that interact with TC10 are unknown, disruption of its activation blocks insulinstimulated glucose transport and Glut4 translocation. Moreover, mistargeting of TC10 to a non-lipid raft domain by production of a TC10/K-Ras chimera, or by disruption of lipid raft microdomains via expression of a dominant-interfering mutant form of caveolin 3 also completely prevented the activation of TC10 by insulin (28) .
Although the precise function of lipid raft subdomains in assembling this signaling complex remains uncertain, resident structural proteins may play an important role. One such protein is caveolin-1, which is highly expressed in mature adipocytes (29) , and is known to undergo tyrosine phosphorylation in various cells (30) (31) (32) (33) . Caveolin is tyrosine phosphorylated in response to insulin in 3T3L1 adipocytes but not fibroblasts (30) .
Although this phosphorylation event correlates well with insulin responsiveness, the significance of caveolin phosphorylation remains uncertain. Moreover, it is unclear whether this phosphorylation event is a direct result of the tyrosine kinase activity of the insulin receptor, or perhaps catalyzed by the Src family kinase Fyn, which is also highly enriched in caveolae of adipocytes (30) . We demonstrate here that insulin receptor physically associates with caveolin in 3T3L1 adipocytes, and further that caveolin is a direct substrate of the insulin receptor.
Experimental Procedures

Materials
The anti-caveolin-2, insulin receptor β subunit and Myc antibodies were purchased from 
Plasmids and mutagenesis
The cDNA of mouse caveolin-1 was amplified by PCR from a 3T3L1 adipocyte cDNA library as the template. The 5' primer was designed to have a BamHI restriction site followed by the amino acids 1 to 27. The 3' primer was designed to have an EcoRI restriction site followed by the amino acids 515 to 537 according to Gene Bank U07645.
These PCR products were cloned into pKMyc vector. FLAG-tagged CAP and CAP mutants were made as described previously (23, 25) . All mutated forms of caveolin-1
were generated using the Stratagene Quick Change Mutagenesis Kit, according to the manufacturer's protocol. The mutations were confirmed by automated DNA sequencing.
Cell culture and transfection
3T3L1 fibroblasts were maintained in DMEM supplemented with 10% calf serum, 100 U/ml penicillin G sodium and 100µg/ml streptomycin sulfate. Differentiation to adipocytes was induced and cells were cultured in DMEM containing 10% fetal bovine serum. 3T3L1 adipocytes were transfected by electroporation as described (23, 25) .
Immunoprecipitation and immunoblotting
Cells were washed twice with ice-cold phosphate-buffered saline, and were lysed for 30 min at 4°C with buffer containing 50mM Tris-HCl(pH8.0), 150mM NaCl, 1% Triton X-100, 1.0mM EDTA, 1.0mM sodium pyrophosphate, 1.0mM sodium orthovanadate, 10mM NaF, and protease inhibitors (1 tablet per 10 ml of buffer) (Roche Diagnostics).
The clarified lysates were incubated with the indicated antibodies for 1hr at 4°C. The immune complexes were precipitated with protein A/G agarose (Santa Cruz, Inc.) for 1 hr at 4°C and were washed extensively with lysis buffer before solubilization in SDS sample buffer. Bound proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Individual proteins were detected with the specific antibodies and visualized by blotting with horseradish peroxidase-conjugated secondary antibodies.
Fractionation of Triton-insoluble pellet
The Triton-insoluble pellet fraction was generated as described previously (21, 30) .
Briefly, cells were washed with ice-cold PBS and lysed in MBS buffer containing protease inhibitors and sodium orthovanadate. Lysed cells were kept at 4°C to prevent degradation of caveolar complexes. The Triton-insoluble pellet fraction was solubilized in SOL buffer containing 60mM octylthioglucoside.
Fluorescence Microscopy
3T3L1 adipocytes were grown on glass cover slips in 6-well dishes. Cell were fixed with 10% formalin for 10 min, permeabilized with 0.5% Triton X-100 for 5 min and then blocked with 3% BSA and 1% ovalbumin for 1 hr. Primary and Alexa Fluor secondary antibodies were used at 2 µg/µl in blocking solution and samples were mounted on glass slides with Vectashield (Vector Laboratories). Cells were imaged using confocal fluorescence microscopy. Fluorescent intensities were quantitated using the Olympus Fluoview software. Images were then imported into Adobe Photoshop (Adobe Systems, Inc.) for processing.
Sucrose gradient centrifugation
Isolation of caveolae-enriched fractions was performed as previously described with minor modifications (30) . Briefly, differentiated 3T3L1 adipocytes were washed with ice-cold PBS, and rapidly scraped in 0.5 M sodium carbonate buffer (pH=11) and homogenized with 10 strokes in a Dounce glass homogenizer. The homogenates were then sonicated 3 times for 20sec at 4.5 setting in a Fisher 550 sonic dismembrator. The samples were combined with 60% (w/v) sucrose in 25mM MES, pH 6.5, 150mM NaCl and mixed well to achieve a final sucrose concentration of 40%. The homogenates were overlaid with 4ml of 35% (w/v) sucrose and then with 3ml of 5% (w/v) sucrose in 25mM MES, pH 6.5, 150mM NaCl. The samples were spun at 39,000 rpm in a SW41 rotor at 4 o C for 19 h and 1 ml fractions were collected for immunoblotting.
Results
The insulin receptor is localized in rosette structures in 3T3L1 adipocytes.
In order to determine whether the tyrosine phosphorylation of caveolin might be catalyzed directly by the insulin receptor, we explored the localization of the receptor in membranes of 3T3L1 adipocytes. Cells were lysed in buffer containing Triton X-100, and purified on sucrose density gradients (Fig. 1) . As previously observed, under these gradient conditions caveolin and flotillin migrate in the low-density region (Fig. 1A, fractions 3-4) of the sucrose gradient consistent with lipid raft enrichment. The insulin receptor was found in the more dense regions of the gradient, but also co-migrated with caveolin 1 and flotillin in the low-density fractions. As expected, insulin stimulation resulted in the recruitment of C3G to the low-density fractions whereas the p85 regulatory subunit of PI 3-kinase was not detected in these fractions, irrespective of insulin treatment (Fig. 1B) . To confirm that a population of the insulin receptor is colocalized with caveolin, plasma membrane sheets were prepared from 3T3-L1 adipocytes (28) , and stained with antibodies to caveolin-2 or the insulin receptor beta subunit. As is seen in Figure 1C , both caveolin and insulin receptor reside in characteristic large clusters of caveolae that take on a rosette or ring-like appearance in adipocytes (28) . Both caveolin-1 and 2 are localized in these structures (data not shown). (23, 25) . To determine whether Cbl/CAP signaling is involved in caveolin-1 phosphorylation, FLAG-tagged CAP, CAP∆SoHo, and CAP∆SH3 were expressed in 3T3-L1 adipocytes. The phosphorylation of caveolin 1 on tyr 14 in response to insulin was evaluated using a phospho-specific antibody (figure 2). Insulin stimulated the tyrosine phosphorylation of caveolin-1, using the phospho-specific antibodies to the sequences surrounding tyr 14 ( Fig. 2D, lanes 1 and 2) . Identical results were generated using antiphosphotyrosine antibodies (data not shown). As previously reported (25) , expression of CAP, CAP∆SoHo, or CAP∆SH3 did not effect the stimulation of Akt or MAPK phosphorylation in response to insulin. Similarly, expression of CAP, CAP∆SoHo, or CAP∆SH3 had no effect on insulin-stimulated caveolin phosphorylation (Fig. 2D, lanes   3-8) , indicating that the Cbl/CAP pathway is not required for phosphorylation of caveolin 1. As controls, the relative expression levels of CAP, CAP∆SoHo, CAP∆SH3 and endogenous caveolin are shown.
Since the tyrosine phosphorylation of caveolin appears to be independent of the CAP/Cbl pathway, we sought to examine the potential role of the PI 3-kinase and MAP kinase pathways in this event (Figure 3 ). 3T3L1 adipocytes were pretreated with PD98059 ( Fig.   3, lanes 3 and 4) , a pharmacological inhibitor of MEK that has been shown to block the MAP kinase pathway (34), as well as Wortmannin (Fig. 3, lanes 5 and 6) , an inhibitor of PI 3-kinase (35), followed by exposure to insulin. As expected, neither inhibitor blocked IRS-1 or insulin receptor tyrosine phosphorylation, (Fig. 3A) , although Wortmannin blocked the phosphorylation of Akt (Fig. 3B) and PD98059 blocked the phosphorylation of MAP kinase (Fig. 3C) . Moreover, the tyrosine phosphorylation of caveolin was unaffected by both inhibitors (Fig. 3D) , indicating that this phosphorylation event is independent of the MAP kinase and PI 3-kinase pathways.
Caveolin 1 was first identified as a tyrosine-phosphorylated protein in v-Src-transformed cells (36) , and is known to be constitutively tyrosine phosphorylated in Src-and Abltransformed cells (33) . Moreover, previous studies (30) revealed that the Src family kinase Fyn is abundant in triton-insoluble low-density complexes derived from 3T3L1 adipocytes. To examine if insulin-stimulated caveolin phosphorylation is a consequence of Fyn activity, 3T3L1 adipocytes were pretreated with the Src family kinase inhibitor PP2 prior to insulin treatment, and caveolin phosphorylation was evaluated (figure 4).
This compound is known to specifically inhibit Src family tyrosine kinases in cells, including the kinase Fyn (37, 38) . The compound had no effect on insulin receptor or IRS-1 tyrosine phosphorylation (Fig. 4A) , or on the activation of Akt (Fig. 4B ) or MAP kinase (Fig. 4C ) in response to insulin. Furthermore, PP2 pretreatment failed to inhibit basal and insulin-stimulated phosphorylation of caveolin 1 (Fig. 4D) . In contrast, PP2 pretreatment completely blocked the constitutive phosphorylation of FAK, a known substrate of Src family kinases such as Fyn (Fig. 4E) , although the dephosphorylation of the protein produced by insulin (39) were myc-tagged, and were expressed at levels roughly equal to those of the endogenous caveolin, as detected by blotting with anti-caveolin antibodies (Fig. 5E ). Expression of wild type caveolin, Cav(Y 14 F) or Cav(C 156 S) had no effect on the stimulation of IR, IRS-1, Akt and ERK phosphorylation in response to insulin (Fig. 5A-C) . Furthermore, the ectopic expression of these proteins did not inhibit the tyrosine phosphorylation of endogenous caveolin 1 (Fig. 5D ). Myc-tagged wild type caveolin was phosphorylated in response to insulin, as was Cav(C 156 S). In contrast, Cav(Y 14 F) did not undergo phosphorylation in response to insulin. Probing this blot with anti-phosphotyrosine antibodies also revealed no phosphorylation (data not shown), indicating that insulin stimulates the phosphorylation of caveolin primarily on tyr 14 . Interestingly, expression of the Y 14 F mutant of caveolin-1 did not produce a dominant-interfering phenotype regarding phosphorylation of the endogenous protein, suggesting that significant overexpression of the protein will be required to observe this effect.
The data described above suggest that caveolin phosphorylation is likely to be catalyzed directly by the insulin receptor. To explore this possibility in more detail, we sought to evaluate a domain on caveolin that is thought to interact with proteins in caveolae.
Caveolin contains a short stretch of amino acids in its amino terminus around residues 80-100 that may mediate these interactions (40), including those with the insulin receptor (41) . To determine whether direct interactions between caveolin-1 and the insulin receptor are required for insulin-stimulated phosphorylation of caveolin, a mutant form of the protein was constructed in which phe 92 and val 94 were mutated to alanine (Cav(FAVA)). This construct was transfected into 3T3L1 adipocytes, along with wild type caveolin-1 ( Figure 6 ). Although the expression levels of Cav(FAVA) were significantly lower than that observed for the wild type form of the protein, it was possible to detect the protein by blotting with anti-myc or anti-caveolin antibodies (Fig.   6C ). Cav(FAVA) was detected at the plasma membrane, and localized in triton-insoluble fractions, typical of wild type caveolin. Moreover, overexpression of this mutant had no effect on the distribution of the insulin receptor in these low-density fractions (data not shown). Expression of wild type caveolin or Cav(FAVA) had no effect on insulin receptor autophosphorylation ( fig. 6A ) or on levels of endogenous caveolin ( fig. 6C ).
However, the tyrosine phosphorylation of endogenous caveolin 1 was significantly inhibited by expression of Cav(FAVA) (Fig. 6B) . Furthermore, expressed Cav(FAVA)
was not phosphorylated in response to insulin, whereas wild type caveolin did undergo tyrosine phosphorylation.
Discussion
Recent evidence suggests that signaling molecules and pathways are restricted to discrete compartments in cells by specific protein interactions. Lipid raft subdomains have been implicated as sites for signal initiation in numerous cell types (42) . In adipocytes and muscle cells, much attention has focused on the caveolae, a subset of lipid raft microdomains. These small invaginations of the plasma membrane are often enriched in signaling molecules, glycolipids and cholesterol, and have been proposed to act as signaling organelles (43) . Based on the identification of a signaling complex in caveolae involving APS, Cbl, CAP, and TC10, we have hypothesized that the segregation to these domains might provide a potential explanation for the specificity of signal transduction in insulin action (2) . Disruption of caveolae with cholesterol extracting drugs such a β-cyclodextrin or expression of a dominant negative form of caveolin 3 (28) blocked specifically the initiation of this pathway, and also prevented the stimulation of glucose transport and Glut4 translocation in response to insulin (44) .
The caveolin family of proteins appears to play a particularly important role in the formation of caveolae, and possibly in signaling activities that occur in these microdomains. Disruption of the gene encoding caveolin 1 results in a failure of lung epithelial cells and adipocytes to form caveolae (45,46), although the impact of this manipulation on signal transduction has not been studied. Numerous studies have demonstrated that caveolin interacts with a number of signaling molecules that are thought to be enriched in caveolae, including certain small and heterotrimeric G proteins (40, 47) , endothelial nitric oxide synthase (48, 49) and a subset of tyrosine kinase receptors (50) , including the insulin receptor (41, 51) . Caveolin is also known to undergo tyrosine phosphorylation in some cases (30) (31) (32) (33) . We first demonstrated that insulin could specifically stimulate the phosphorylation of caveolin in 3T3L1 adipocytes (31) . This effect of the hormone was rapid, dose-dependent and specific for insulin. Interestingly, the effect was not observed in 3T3L1 preadipocytes, which express both caveolin and the insulin receptor, suggesting that caveolin phosphorylation correlates with metabolic responsiveness to insulin (30) .
Although the mechanism involved in the insulin-stimulated phosphorylation of caveolin has not been established, previous studies suggested that the Src family kinase Fyn might catalyze this event (30) . Fyn is highly expressed n 3T3L1 adipocytes and copurifies with caveolin in triton-insoluble low-density complexes. Moreover, caveolin undergoes hyperphosphorylation upon overexpression of Fyn in these cells (30) . However, the data presented in this study strongly supports a direct insulin receptor mediated tyrosine phosphorylation of caveolin on tyr 14 as a consequence of phosphorylation on tyr 14 , it is possible to speculate about phosphotyrosine-dependent interactions that might recruit proteins to these domains in an insulin-dependent manner, perhaps via SH2 interactions. In this regard, Grb7 and 14
have been proposed to interact with caveolin in a tyrosine phosphorylation-dependent manner (33), although we have been unable to detect insulin-dependent interactions with these adapter proteins in adipocytes (data not shown). It is also possible that caveolin might itself regulate the activity of the insulin receptor, increasing its activity toward other substrates (41) . Finally, the possibility remains that the tyrosine phosphorylation of caveolin by the insulin receptor is merely a result of the interaction of these two molecules, and further that the binding of caveolin to the receptor helps to recruit the latter protein to caveolae, where it initiates the CAP/Cbl signaling pathway. These possibilities will be the subject of future studies. 
